CARDIFF ONCOLOGY, INC. Other Nonoperating Income (Expense)
CARDIFF ONCOLOGY, INC. (CRDF) reported Other Nonoperating Income (Expense) of $1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was $1.00K.
- CARDIFF ONCOLOGY, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$1.00K, a 114.29% decline year-over-year.
- CARDIFF ONCOLOGY, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$1.00K.
- CARDIFF ONCOLOGY, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. other nonoperating income (expense) for fiscal 2025 was $5.00K.
- CARDIFF ONCOLOGY, INC. other nonoperating income (expense) for fiscal 2024 was -$39.00K.
- CARDIFF ONCOLOGY, INC. other nonoperating income (expense) for fiscal 2023 was -$98.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | -$1.00K derived: sum of 3 quarters · filed 2026-08-11 | -$1.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | -$1.00K 10-Q · filed 2026-05-14 | -$2.00K derived: sum of 2 quarters · filed 2026-05-14 | -$2.00K derived: sum of 3 quarters · filed 2026-05-14 | -$3.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.00K derived: sum of 2 quarters · filed 2026-02-24 | -$2.00K derived: sum of 3 quarters · filed 2026-08-11 | $5.00K 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | -$1.00K derived: sum of 2 quarters · filed 2026-08-11 | $6.00K 10-Q · filed 2025-11-06 | $4.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | -$1.00K 10-Q · filed 2026-08-11 | $6.00K 10-Q · filed 2026-08-11 | $4.00K derived: sum of 3 quarters · filed 2026-08-11 | $9.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $7.00K 10-Q · filed 2026-05-14 | $5.00K derived: sum of 2 quarters · filed 2026-05-14 | $10.00K derived: sum of 3 quarters · filed 2026-05-14 | -$28.00K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.00K derived: sum of 2 quarters · filed 2026-02-24 | -$35.00K derived: sum of 3 quarters · filed 2026-02-24 | -$39.00K 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $5.00K 10-Q · filed 2025-11-06 | -$33.00K derived: sum of 2 quarters · filed 2025-11-06 | -$37.00K 10-Q · filed 2025-11-06 | -$50.00K derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | -$38.00K 10-Q · filed 2025-07-29 | -$42.00K 10-Q · filed 2025-07-29 | -$55.00K derived: sum of 3 quarters · filed 2025-07-29 | -$34.00K derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2024-03-31 | -$4.00K 10-Q · filed 2025-05-08 | -$17.00K derived: sum of 2 quarters · filed 2025-05-08 | $4.00K derived: sum of 3 quarters · filed 2025-05-08 | $9.00K derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $8.00K derived: sum of 2 quarters · filed 2025-02-27 | $13.00K derived: sum of 3 quarters · filed 2025-02-27 | -$98.00K 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $21.00K 10-Q · filed 2024-11-07 | $26.00K derived: sum of 2 quarters · filed 2024-11-07 | -$85.00K 10-Q · filed 2024-11-07 | ||||
| 2023-06-30 | $5.00K 10-Q · filed 2024-08-08 | -$106.00K 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | -$111.00K 10-Q · filed 2024-05-02 | ||||||
| 2022-09-30 | -$36.00K 10-Q · filed 2023-11-02 | -$289.00K derived: sum of 2 quarters · filed 2023-11-02 | -$338.00K 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | -$253.00K 10-Q · filed 2023-08-09 | -$302.00K 10-Q · filed 2023-08-09 | |||||
| 2022-03-31 | -$49.00K 10-Q · filed 2023-05-04 | ||||||
| 2021-09-30 | $3.00K 10-Q · filed 2022-11-03 | $3.00K derived: sum of 2 quarters · filed 2022-11-03 | $15.00K 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $12.00K 10-Q · filed 2022-08-04 | |||||
| 2021-03-31 | -$1.00K 10-Q · filed 2022-05-05 | ||||||
| 2020-09-30 | -$6.00K 10-Q · filed 2021-11-04 | -$5.74K 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | -$2.00K 10-Q · filed 2021-11-04 | -$1.97K 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $6.00K 10-Q · filed 2021-08-05 | $6.26K 10-Q · filed 2020-08-11 | $4.00K 10-Q · filed 2021-08-05 | $3.77K 10-Q · filed 2020-08-11 | |||
| 2020-03-31 | -$3.00K 10-Q · filed 2021-05-06 | -$2.49K 10-Q · filed 2020-05-07 | |||||
| 2019-09-30 | -$1.10K 10-Q · filed 2020-11-05 | $3.00 derived: sum of 2 quarters · filed 2020-11-05 | $2.01K 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | $1.11K 10-Q · filed 2020-08-11 | $3.12K 10-Q · filed 2020-08-11 | |||||
| 2019-03-31 | $2.01K 10-Q · filed 2020-05-07 | ||||||
| 2018-09-30 | $2.32K 10-Q · filed 2019-11-07 | -$69.52K derived: sum of 2 quarters · filed 2019-11-07 | -$68.52K 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | -$71.84K 10-Q · filed 2019-08-08 | -$70.84K 10-Q · filed 2019-08-08 | |||||
| 2018-03-31 | $1.00K 10-Q · filed 2019-05-07 | ||||||
| 2017-09-30 | -$6.54K 10-Q · filed 2018-11-07 | -$4.97K derived: sum of 2 quarters · filed 2018-11-07 | -$4.97K 10-Q · filed 2018-11-07 | ||||
| 2017-06-30 | $1.57K 10-Q · filed 2018-08-03 | $1.57K 10-Q · filed 2018-08-03 | |||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | ||||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | |||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | ||||||
| 2015-09-30 | -$8.13K 10-Q · filed 2016-11-09 | $1.05K derived: sum of 2 quarters · filed 2016-11-09 | $4.62K 10-Q · filed 2016-11-09 | ||||
| 2015-06-30 | $9.18K 10-Q · filed 2016-08-04 | $12.75K 10-Q · filed 2016-08-04 | |||||
| 2015-03-31 | $3.57K 10-Q · filed 2016-05-10 | ||||||
| 2014-09-30 | -$19.25K 10-Q · filed 2015-11-09 | $24.84K 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | $44.10K 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |